跳至主要内容
临床试验/NCT07455591
NCT07455591已完成4 期

A Prospective Randomised Pilot Trial Of The Supplemental Use Of Intraoperative Fibrin Sealant Alongside TXA On Postoperative Recovery After Total Knee Replacement

Singapore General Hospital1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2024年1月1日最近更新:
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
78
试验地点
1
主要终点
Serum Hb

研究概览

简要总结

This study is conducted as a pilot trial to assess the added benefit of the VeraSeal fibrin sealant to TXA on postoperative outcomes following TKR. Informed consent is obtained from all participants prior to inclusion in the study. Patients are prospectively recruited from a consecutive series of TKR procedures performed for end-stage osteoarthritis. Recruited patients were randomised into two cohorts: those receiving intra-articular tranexamic acid (TXA) alone, and those receiving intra-articular TXA and VeraSeal fibrin sealant (TXA+Sealant). Randomisation is performed just prior to surgery using a digital random allocation generator by the surgical team. Patients and physiotherapists responsible for outcome data collection are blinded to group allocation throughout the study period.

Intraoperative administration of the sealant is performed after prosthetic implantation, which was followed by topical intra-articular TXA. In the TXA group, TXA is applied intraoperatively into the joint capsule prior to closure. In the TXA+Sealant group, VeraSeal was applied evenly onto subcutaneous tissues, synovium and exposed bony surfaces within the joint capsule and allowed to cure. The same dose of topical TXA was infiltrated after VeraSeal had cured, prior to closure. All other pathways were standard per hospital protocols.

Preoperatively, demographic data including age, sex, height, and weight, as well as serum haemoglobin (Hb) levels were collected for all patients. Primary outcomes were collected on postoperative day 1: serum Hb, knee flexion range of motion (°), ambulation distance (m), and rest and ambulatory pain visual analogue scales (VAS) between 0 (no pain) and 10 (worst pain) were collected. All patients were inpatient during primary outcome data collection. Secondary outcomes included: Oxford Knee Score (0-48, higher is better), American Knee Society Score (0-100, higher is better), and SF-36 Score (0-100, higher is better), collected pre-operatively and 6 months post-operatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fits clinically-assessed criteria for total knee replacement

排除标准

  • 未提供

研究组 & 干预措施

TXA

Active Comparator

1.5g of TXA was diluted in 100 mL of saline and applied intraoperatively into the joint capsule prior to closure.

干预措施: Tranexamic Acid (TXA) (Drug)

TXA+Sealant

Experimental

VeraSeal was applied evenly onto subcutaneous tissues, synovium and exposed bony surfaces within the joint capsule and allowed to cure and form clots for 60 seconds. Following this, 1.5g of TXA was diluted in 100 mL of saline and applied intraoperatively into the joint capsule prior to closure,

干预措施: fibrin sealant (Drug)

TXA+Sealant

Experimental

VeraSeal was applied evenly onto subcutaneous tissues, synovium and exposed bony surfaces within the joint capsule and allowed to cure and form clots for 60 seconds. Following this, 1.5g of TXA was diluted in 100 mL of saline and applied intraoperatively into the joint capsule prior to closure,

干预措施: Tranexamic Acid (TXA) (Drug)

结局指标

主要结局

Serum Hb

时间窗: Preoperatively and one day after surgery

Serum Haemoglobin (g/dL)

Knee Flexion ROM

时间窗: Preoperatively and one day after surgery

Knee flexion range of motion (°)

Ambulation Distance

时间窗: One day after surgery

Ambulation distance (m)

Rest Pain Score

时间窗: One day after surgery

Rest pain visual analogue scales (VAS) between 0 (no pain) and 10 (worst pain)

Ambulatory Pain Score

时间窗: One day after surgery

Ambulatory pain visual analogue scales (VAS) between 0 (no pain) and 10 (worst pain)

次要结局

  • PROMs - OKS(Pre-operatively and 6 months post-operatively)
  • PROMs - AKSS(6 months post-operatively)
  • PROMs - SF-36(6 months post-operatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lincoln Liow Ming Han

Consultant in Orthopaedic Surgery (Adult Reconstruction)

Singapore General Hospital

研究点 (1)

Loading locations...

相似试验